Fibrous scaffolds as carrier matrices for printed drug delivery systems – Presented by Mirja Palo, Pharmaceutical Sciences Laboratory, Åbo Akademi University

Fibrous scaffolds as carrier matrices for printed drug delivery systems – Presented by Mirja Palo, Pharmaceutical Sciences Laboratory, Åbo Akademi University at The 3D Medicine & Pharmaceutical Printing Conference which will take place on  Feb 01, 2017 at MECC Maastricht in The Netherlands. Continue reading “Fibrous scaffolds as carrier matrices for printed drug delivery systems – Presented by Mirja Palo, Pharmaceutical Sciences Laboratory, Åbo Akademi University”

Emergence of 3D printed dosage forms: A focus on FDM 3D printing – Presented by Mohamed Albed Alhnan, University of Central Lancashire

Mohamed Albed Alhnan

Emergence of 3D printed dosage forms: A focus on FDM 3D printing – Presented by Mohamed Albed Alhnan, University of Central Lancashire, School of Pharmacy and Biomedical Sciences at The 3D Medicine & Pharmaceutical Printing Conference which will take place on  Feb 01, 2017 at MECC Maastricht in The Netherlands. Continue reading “Emergence of 3D printed dosage forms: A focus on FDM 3D printing – Presented by Mohamed Albed Alhnan, University of Central Lancashire”

Tikcit is registration platform partner of 3D Medicine Printing Conference

Tikcit is registration platform partner of 3D Medicine Printing Conference, which will take place on Feb 01, 2017 at MECC Maastricht in The Netherlands

About Tikcit
Organising an event implies many issues, from ticketing to e-payments, from statistics to ordering supplies, from surveys to social media and many many more. Tikcit is the platform to support you. Continue reading “Tikcit is registration platform partner of 3D Medicine Printing Conference”

“3D-printing of tablets and opportunities in the field of personalized medicine” – Presented by Steven Erpelinck, TNO Predictive Health Technologies

“3D-printing of tablets and opportunities in the field of personalized medicine” – Presented by Steven Erpelinck, TNO Predictive Health Technologies. 3D printing is a promising technique which has shown to deliver added value within the development of personalized medicine. Currently different 3D printing technologies can be discriminated. Different 3D printing techniques will be presented. Continue reading ““3D-printing of tablets and opportunities in the field of personalized medicine” – Presented by Steven Erpelinck, TNO Predictive Health Technologies”

“The regulatory perspective: benefits and limits of 3D printed drugs” – Presented by Dr. William Shang, Johnson & Johnson

Dr. William Shang

“The regulatory perspective: benefits and limits of 3D printed drugs” – Presented by Dr. William Shang, Johnson & Johnson. 3DP technology is already up and running in many areas. The future definitely looks promising when considering the idea of 3DPs, but are the regulatory agencies ready for such technology? The presentation will reflect the regulators views and concerns about pharmaceutical development, manufacturing and control of this new technology. Potential clinical and preclinical obstacles in terms of practical use will be addressed as well.

About Dr. William Shang Continue reading ““The regulatory perspective: benefits and limits of 3D printed drugs” – Presented by Dr. William Shang, Johnson & Johnson”

“Legal Issues around 3D Printed Drugs” – Presented by An Vijverman, Dewallens & Partners Law Firm

“Legal Issues around 3D Printed Drugs” – Presented by Ann Vijverman, Dewallens & Partners Law Firm.In this presentation it will be analyzed whether and how 3D printed Drugs could fit within the actual legal framework concerning medicinal products: can the 3D printed drug qualify as an industrially prepared medicinal product; or as a magistral or officinal formula; or as an ATMP; or as a bona fida unsolicited order; or …? And what about the applicable GMP requirements? And how will 3D drug printing comply with the applicable data protection legislation? Continue reading ““Legal Issues around 3D Printed Drugs” – Presented by An Vijverman, Dewallens & Partners Law Firm”